Skylink Holdings: Insider Purchase of CEO, Mr Shen Wende @ S$0.212 per share on 12 August
Skylink Holdings Limited’s Director and CEO, Mr. Shen Wende, has acquired 200,000 ordinary shares in the Company via a market transaction on 12 August 2026.
The shares were acquired for a total consideration of S$42,400, representing an average acquisition price of S$0.212 per share. Following the transaction, Mr. Shen’s direct interest increased from 200,000 shares to 400,000 shares.
Skylink Holdings Limited’s Director and CEO, Mr. Shen Wende, has acquired 200,000 ordinary shares in the Company via a market transaction on 12 August 2026.
The shares were acquired for a total consideration of S$42,400, representing an average acquisition price of S$0.212 per share. Following the transaction, Mr. Shen’s direct interest increased from 200,000 shares to 400,000 shares.
Winking Studios: Strong 1H2026 revenue growth, with accelerated strategic investments supporting the Group’s next
phase of growth
• Organic revenue growth of 8.9%, with Art Outsourcing revenue up 25.4%.
• Follow-up projects represented 37.4% of revenue (1H2025: 38.8%).
• Strong progress towards diversification of revenue streams, with Japan revenue more than doubling to US$3.6 million in 1H2026.
• The decrease in gross margin reflected accelerated investment in Ampera and AI-enabled game development as well as Mineloader’s seasonally softer first quarter (which was acquired in 2Q2025).
• Healthy balance sheet with cash, cash equivalents and bond investments of US$24.6 million as at 30 June 2026, as well as low gearing.
• Executive Director and Chief Executive Officer (Founder) of Winking Studios, Johnny Jan, commented:
“The first half demonstrates the strength of our core business and the scale of the opportunity we are building towards. Revenue grew by 21%, led by strong demand for art outsourcing, while repeat business and our bookings provide good visibility over underlying activity.
At the same time, we chose to accelerate investment in two areas where we see significant long-term potential: building a stronger North American presence through the acquisition of and further investment into Ampera and developing AI-enabled game development capabilities. We are encouraged by the larger opportunities
entering the Ampera pipeline and the early commercial traction we are seeing from AI-enabled game
development.
Our AI initiative is principally focused on enhancing game-development workflows. Game art production continues to depend on human creativity, artistic judgement and rigorous quality control.
Our focus is on building Winking Studios into a broader, end-to-end game development partner that combines high-quality creative production, game development capability and global delivery. We believe the investments we are making now will strengthen our competitive position and support sustainable long-term growth.”
See link for full release here: https://investor.winkingworks.com/view&id=128
phase of growth
• Organic revenue growth of 8.9%, with Art Outsourcing revenue up 25.4%.
• Follow-up projects represented 37.4% of revenue (1H2025: 38.8%).
• Strong progress towards diversification of revenue streams, with Japan revenue more than doubling to US$3.6 million in 1H2026.
• The decrease in gross margin reflected accelerated investment in Ampera and AI-enabled game development as well as Mineloader’s seasonally softer first quarter (which was acquired in 2Q2025).
• Healthy balance sheet with cash, cash equivalents and bond investments of US$24.6 million as at 30 June 2026, as well as low gearing.
• Executive Director and Chief Executive Officer (Founder) of Winking Studios, Johnny Jan, commented:
“The first half demonstrates the strength of our core business and the scale of the opportunity we are building towards. Revenue grew by 21%, led by strong demand for art outsourcing, while repeat business and our bookings provide good visibility over underlying activity.
At the same time, we chose to accelerate investment in two areas where we see significant long-term potential: building a stronger North American presence through the acquisition of and further investment into Ampera and developing AI-enabled game development capabilities. We are encouraged by the larger opportunities
entering the Ampera pipeline and the early commercial traction we are seeing from AI-enabled game
development.
Our AI initiative is principally focused on enhancing game-development workflows. Game art production continues to depend on human creativity, artistic judgement and rigorous quality control.
Our focus is on building Winking Studios into a broader, end-to-end game development partner that combines high-quality creative production, game development capability and global delivery. We believe the investments we are making now will strengthen our competitive position and support sustainable long-term growth.”
See link for full release here: https://investor.winkingworks.com/view&id=128
Winking Studios - Art Outsourcing 2D / 3D
Home - Winking Studios - Art Outsourcing 2D / 3D
Winking Studios, listed on the Singapore Exchange (Trading Code: WKS), is one of the largest Art Outsourcing and game development studios globally. Clients of our Art Outsourcing and Game Development services include 19 of the top 25 game publishers around…
Lincotrade: Positive Guidance - Significant Improvement in Profit before Tax for FY2026
The Board of Directors (“Board”) of Lincotrade & Associates Holdings Limited (the “Company” and together with its subsidiaries, collectively the “Group”) wishes to inform shareholders of the Company that the Group is expected to report a significant improvement in profit before tax (“PBT”) for the financial year ended 30 June 2026 (“FY2026”), as compared to the financial year ended 30 June 2025 (“FY2025”).
Based on the preliminary review of the Group’s unaudited consolidated financial results for FY2026, the expected improvement in PBT is mainly attributable to the execution of ongoing projects from a higher outstanding order book undertaken in FY2026 in line with the announcement dated 29 May 2026, compared to FY2025. The Group is still in the process of finalising its unaudited consolidated financial results for FY2026 and will provide further details of the Group’s financial performance when it is released on or before 29 August 2026.
The information contained in this announcement is based on the preliminary assessment of the financial results for FY2026, which has yet to be reviewed or finalised by the Board, nor reviewed by the external auditors of the Company. Shareholders and investors are advised to exercise caution when dealing in the shares of the Company. Persons who are in doubt as to the action they should take should consult their stockbroker, bank manager, solicitor, accountant or other professional advisers.
See link for full media release: https://www.lincotrade.com.sg/frontend/web/index.php?r=attachment/download&id=1032
The Board of Directors (“Board”) of Lincotrade & Associates Holdings Limited (the “Company” and together with its subsidiaries, collectively the “Group”) wishes to inform shareholders of the Company that the Group is expected to report a significant improvement in profit before tax (“PBT”) for the financial year ended 30 June 2026 (“FY2026”), as compared to the financial year ended 30 June 2025 (“FY2025”).
Based on the preliminary review of the Group’s unaudited consolidated financial results for FY2026, the expected improvement in PBT is mainly attributable to the execution of ongoing projects from a higher outstanding order book undertaken in FY2026 in line with the announcement dated 29 May 2026, compared to FY2025. The Group is still in the process of finalising its unaudited consolidated financial results for FY2026 and will provide further details of the Group’s financial performance when it is released on or before 29 August 2026.
The information contained in this announcement is based on the preliminary assessment of the financial results for FY2026, which has yet to be reviewed or finalised by the Board, nor reviewed by the external auditors of the Company. Shareholders and investors are advised to exercise caution when dealing in the shares of the Company. Persons who are in doubt as to the action they should take should consult their stockbroker, bank manager, solicitor, accountant or other professional advisers.
See link for full media release: https://www.lincotrade.com.sg/frontend/web/index.php?r=attachment/download&id=1032
20260814.Fuxing_Bonus_Issue_Announcement_FINAL.pdf
176 KB
FUXING (4th Largest Zipper Manufacturer Globally) - Bonus Issuance: one (1) Bonus Share for every two (2) existing ordinary shares
1.Winking-Studios-Limited-1H2026 Results Statements.pdf
796.4 KB
Winking Studios: Strong revenue growth, with accelerated strategic investments supporting the Group’s next phase of growth
Winking Studios Continues Share Buyback on 14 Aug 2026
Winking Studios has completed a further purchase of 92,500 ordinary shares pursuant to its ongoing share buyback programme.
The shares were acquired through market purchases at S$0.21 per share, for a total consideration of S$19,486.19. Following the transaction, the Company's treasury shares increased to 757,100 shares, representing approximately 0.17% of its issued shares (excluding treasury shares).
The continued execution of the share buyback programme reflects the Board's disciplined approach to capital allocation and its previously stated belief that the current market value of the Company's ordinary shares does not appropriately reflect the underlying value of the Group.
As one of the world's largest AAA game art outsourcing studios and an established game development company, Winking Studios remains focused on executing its long-term growth strategy while creating sustainable value for shareholders.
See link for more details: https://investor.winkingworks.com/newsroom
Winking Studios has completed a further purchase of 92,500 ordinary shares pursuant to its ongoing share buyback programme.
The shares were acquired through market purchases at S$0.21 per share, for a total consideration of S$19,486.19. Following the transaction, the Company's treasury shares increased to 757,100 shares, representing approximately 0.17% of its issued shares (excluding treasury shares).
The continued execution of the share buyback programme reflects the Board's disciplined approach to capital allocation and its previously stated belief that the current market value of the Company's ordinary shares does not appropriately reflect the underlying value of the Group.
As one of the world's largest AAA game art outsourcing studios and an established game development company, Winking Studios remains focused on executing its long-term growth strategy while creating sustainable value for shareholders.
See link for more details: https://investor.winkingworks.com/newsroom
Winking Studios - Art Outsourcing 2D / 3D
Home - Winking Studios - Art Outsourcing 2D / 3D
Winking Studios, listed on the Singapore Exchange (Trading Code: WKS), is one of the largest Art Outsourcing and game development studios globally. Clients of our Art Outsourcing and Game Development services include 19 of the top 25 game publishers around…
Beng Kuang Marine: Insider Purchases @ 45 cents
Chairman Chua Beng Yong acquires 50,000 shares at 45 cents on 14 Aug 2026.
Barring unforeseen circumstances, the Group's revenue and margins are expected to strengthen progressively through 2H2026 with outstanding contracted work of approximately S$70.7 million.
• 1H2026's financial results reflected only approximately one month of full ownership of ASOM, which
will thereafter contribute a full six months of financial performance in 2H2026, providing a more
meaningful representation of its earnings contribution.
• New order wins exceeded revenue recognised during the period with approximately S$85.2 million of
new contracts and purchase orders secured during 1H2026, representing an order intake-to-revenue
ratio of approximately 1.5x.
See more here: https://www.bkmgroup.com.sg/view&id=1389
Chairman Chua Beng Yong acquires 50,000 shares at 45 cents on 14 Aug 2026.
Barring unforeseen circumstances, the Group's revenue and margins are expected to strengthen progressively through 2H2026 with outstanding contracted work of approximately S$70.7 million.
• 1H2026's financial results reflected only approximately one month of full ownership of ASOM, which
will thereafter contribute a full six months of financial performance in 2H2026, providing a more
meaningful representation of its earnings contribution.
• New order wins exceeded revenue recognised during the period with approximately S$85.2 million of
new contracts and purchase orders secured during 1H2026, representing an order intake-to-revenue
ratio of approximately 1.5x.
See more here: https://www.bkmgroup.com.sg/view&id=1389
www.bkmgroup.com.sg
Beng Kuang Group - Newsroom
*Coal Remains The Undisputed King Of Global Power*
- Coal remains the world’s largest power source, generating nearly 11,000 TWh in 2026—77% more electricity than wind and solar combined.
- The Iran war is giving coal an unexpected boost, as disrupted LNG supplies and higher gas prices make coal more competitive in Europe and Asia.
- Renewables are growing rapidly, but soaring electricity demand is slowing coal’s displacement, with the IEA expecting coal to remain the largest individual power source through 2030.
https://oilprice.com/Energy/Coal/Coal-Remains-The-Undisputed-King-Of-Global-Power.html
- Coal remains the world’s largest power source, generating nearly 11,000 TWh in 2026—77% more electricity than wind and solar combined.
- The Iran war is giving coal an unexpected boost, as disrupted LNG supplies and higher gas prices make coal more competitive in Europe and Asia.
- Renewables are growing rapidly, but soaring electricity demand is slowing coal’s displacement, with the IEA expecting coal to remain the largest individual power source through 2030.
https://oilprice.com/Energy/Coal/Coal-Remains-The-Undisputed-King-Of-Global-Power.html
🌈**IX BIOPHARMA FY2026 – Key Highlights**
*Increased Revenue from US and Higher Gross Margins in FY2026 Validate Business Pivot to US*
1. Strong growth in US contribution
• US revenue increased more than 14x to S$1.98 million in FY2026, from S$0.14 million in FY2025.
• US growth offset approximately two-thirds of the medicinal cannabis revenue shortfall within one year.
• Excluding medicinal cannabis, the Group's other businesses grew 144% year-on-year.
2. Gross profit and gross margin improved
• Gross profit increased 19% to S$2.43 million from S$2.04 million, despite lower overall revenue.
• Gross margin expanded to 36%, from 26% in FY2025.
• Q4 gross margin further improved to 48%, from 32% in the corresponding period.
3. Stronger cash position and balance sheet
• Cash and cash equivalents increased to S$14.16 million as at 30 June 2026, from S$0.33 million as at 30 June 2025.
• The Group restored positive working capital of S$8.61 million, compared with a working capital deficiency of S$4.77 million previously.
• The Group raised gross proceeds of approximately S$6.7 million in October 2025 and S$15.0 million in February 2026, supporting US expansion, interim requirements relating to the DoD contract, general working capital and debt reduction.
4. Loss narrowed, despite lower revenue
• Loss for FY2026 narrowed 21% to S$7.99 million, from S$10.14 million in FY2025.
• The improvement was achieved despite lower overall revenue, supported by higher gross profit and stronger gross margins.
5. Secured US$40.95 million US Department of Defense contract
• Secured a US$40.95 million sole-source contract from the US Department of Defense in February 2026.
• The contract supports Phase 3 clinical development of Wafermine, the Group's patented sublingual ketamine wafer for acute moderate-to-severe pain.
• Work commenced during FY2026 and contributed S$1.25 million in product development revenue, while the Group progresses an Emergency Use Authorization (EUA) pathway for DoD use.
6. Rapid expansion of US commercial product sales
• Sales of products supplied from the Australian facility to the US increased approximately 429% to S$0.74 million.
• SL-NAD+ and Wafesil accounted for more than 90% of these sales.
• The Group plans to supply products through the US compounding pharmacy channel following commissioning of its Nevada facility, enabling immediate monetisation of selected products without further clinical development.
7. Establishing a US manufacturing footprint
• The Group is relocating freeze-drying equipment from Australia to Nevada, US, supporting commercial and production readiness under the DoD contract and US compounding pharmacy pathway.
• The move is expected to strengthen supply-chain resilience and cost competitiveness while mitigating potential tariff-related headwinds.
8. Pipeline of approximately 40 novel products
• iX Biopharma has developed a pipeline of approximately 40 novel products leveraging its proprietary sublingual technologies.
• The pipeline includes longevity and lifestyle products targeting high-value therapeutic areas such as men's health, hormone replacement therapy, and peptides.
9. Multiple catalysts to drive the next phase of growth
• Advancing Wafermine's Emergency Use Authorisation (EUA) application and Phase 3 development under the DoD contract.
• Commissioning of the Nevada manufacturing facility to support US production and commercialisation.
• Scaling commercial product supply into the US, the world's largest healthcare market.
• Continued development and commercialisation of the Group's broader product pipeline.
*Increased Revenue from US and Higher Gross Margins in FY2026 Validate Business Pivot to US*
1. Strong growth in US contribution
• US revenue increased more than 14x to S$1.98 million in FY2026, from S$0.14 million in FY2025.
• US growth offset approximately two-thirds of the medicinal cannabis revenue shortfall within one year.
• Excluding medicinal cannabis, the Group's other businesses grew 144% year-on-year.
2. Gross profit and gross margin improved
• Gross profit increased 19% to S$2.43 million from S$2.04 million, despite lower overall revenue.
• Gross margin expanded to 36%, from 26% in FY2025.
• Q4 gross margin further improved to 48%, from 32% in the corresponding period.
3. Stronger cash position and balance sheet
• Cash and cash equivalents increased to S$14.16 million as at 30 June 2026, from S$0.33 million as at 30 June 2025.
• The Group restored positive working capital of S$8.61 million, compared with a working capital deficiency of S$4.77 million previously.
• The Group raised gross proceeds of approximately S$6.7 million in October 2025 and S$15.0 million in February 2026, supporting US expansion, interim requirements relating to the DoD contract, general working capital and debt reduction.
4. Loss narrowed, despite lower revenue
• Loss for FY2026 narrowed 21% to S$7.99 million, from S$10.14 million in FY2025.
• The improvement was achieved despite lower overall revenue, supported by higher gross profit and stronger gross margins.
5. Secured US$40.95 million US Department of Defense contract
• Secured a US$40.95 million sole-source contract from the US Department of Defense in February 2026.
• The contract supports Phase 3 clinical development of Wafermine, the Group's patented sublingual ketamine wafer for acute moderate-to-severe pain.
• Work commenced during FY2026 and contributed S$1.25 million in product development revenue, while the Group progresses an Emergency Use Authorization (EUA) pathway for DoD use.
6. Rapid expansion of US commercial product sales
• Sales of products supplied from the Australian facility to the US increased approximately 429% to S$0.74 million.
• SL-NAD+ and Wafesil accounted for more than 90% of these sales.
• The Group plans to supply products through the US compounding pharmacy channel following commissioning of its Nevada facility, enabling immediate monetisation of selected products without further clinical development.
7. Establishing a US manufacturing footprint
• The Group is relocating freeze-drying equipment from Australia to Nevada, US, supporting commercial and production readiness under the DoD contract and US compounding pharmacy pathway.
• The move is expected to strengthen supply-chain resilience and cost competitiveness while mitigating potential tariff-related headwinds.
8. Pipeline of approximately 40 novel products
• iX Biopharma has developed a pipeline of approximately 40 novel products leveraging its proprietary sublingual technologies.
• The pipeline includes longevity and lifestyle products targeting high-value therapeutic areas such as men's health, hormone replacement therapy, and peptides.
9. Multiple catalysts to drive the next phase of growth
• Advancing Wafermine's Emergency Use Authorisation (EUA) application and Phase 3 development under the DoD contract.
• Commissioning of the Nevada manufacturing facility to support US production and commercialisation.
• Scaling commercial product supply into the US, the world's largest healthcare market.
• Continued development and commercialisation of the Group's broader product pipeline.
Construction boom is not over!
From: DBS Insights Direct 24 Aug 2026
Singapore Construction: Extending the building boom from NDP26
The government unveiled major offshore development plans spanning a new western industrial island, the rejuvenation of Sentosa and Pulau Brani, further reclamation at Pulau Tekong and new transport links
These developments should provide a sustained pipeline of projects, reinforcing visibility beyond the current construction upcycle and easing concerns over a potential slowdown in contract awards
Early beneficiaries include Wee Hur, Centurion Corp and CAREIT from accommodation demand as contractors mobilise labour ; Hock Lian Seng (NR) for its speciality on land reclamation; ASL Marine (NR) as they own and operates barges that are used to transport materials including sand
In the medium term, Pan Utd and Hong Leong Asia will see heightened demand for their concrete solutions as construction dials up.
What has happened?
In the National Day Rally 2026 (NDP26), the government unveiled further insights into Singapore’s longer term growth plans. Amongst them, in the longer term, a new western island to support a new generation of industries, including advanced manufacturing and power-generation infrastructure, as well as facilities for the Singapore Armed Forces. A new transport link will connect Jurong Island to the proposed island. Sentosa is also set to undergo another major rejuvenation, with enhancements to its beaches and waterfront and improved public access to parts of its western coastline. Following the relocation of port operations, Pulau Brani will be transformed with new attractions, including NTUC’s Downtown South resort. Reclamation and new transport links will better connect Pulau Brani and Sentosa, creating an integrated leisure and tourism destination. Meanwhile, Pulau Tekong could undergo further reclamation along its southern coast, while the government is studying a permanent connection to mainland Singapore, potentially through an undersea tunnel to avoid obstructing shipping channels.
Our view.
These developments should provide a sustained pipeline of reclamation, marine engineering and infrastructure projects, reinforcing visibility beyond the current construction upcycle and easing investor concerns over a potential slowdown in contract awards from 2027 onwards. With expected multi-year construction works in the offing, we believe that early beneficiaries from this 2026 will likely those specialised civil-engineering contractors. Amongst our scan of such players, we note that Hock Lian Seng (Non-rated) appears to a primary direct beneficiary given its track record and focus on dredging works, reclamation and seawall construction, unrestricted BCA A1 civil-engineering licence. Centurion (BUY, TP SGD 1.86), Wee Hur (BUY, TP SGD 0.90) and CAREIT (BUY, TP SGD 1.30) are also early beneficiaries, gaining from initial reclamation and marine-engineering works and higher worker-accommodation demand as contractors mobilise labour. ASL Marine (Non-Rated) could benefit through its fleet of barges, which are used to transport materials, including sand, for reclamation projects. In the medium term, material providers Pan-United (BUY, TP SGD 1.88) and Hong Leong Asia (BUY, TP SGD 5.40) should benefit later as construction progresses to the more concrete-intensive development of seawalls, tunnels, transport links, utilities and buildings. While timelines and project values have yet to be announced, the plans strengthen the sector’s medium- to long-term order-book outlook.
From: DBS Insights Direct 24 Aug 2026
Singapore Construction: Extending the building boom from NDP26
The government unveiled major offshore development plans spanning a new western industrial island, the rejuvenation of Sentosa and Pulau Brani, further reclamation at Pulau Tekong and new transport links
These developments should provide a sustained pipeline of projects, reinforcing visibility beyond the current construction upcycle and easing concerns over a potential slowdown in contract awards
Early beneficiaries include Wee Hur, Centurion Corp and CAREIT from accommodation demand as contractors mobilise labour ; Hock Lian Seng (NR) for its speciality on land reclamation; ASL Marine (NR) as they own and operates barges that are used to transport materials including sand
In the medium term, Pan Utd and Hong Leong Asia will see heightened demand for their concrete solutions as construction dials up.
What has happened?
In the National Day Rally 2026 (NDP26), the government unveiled further insights into Singapore’s longer term growth plans. Amongst them, in the longer term, a new western island to support a new generation of industries, including advanced manufacturing and power-generation infrastructure, as well as facilities for the Singapore Armed Forces. A new transport link will connect Jurong Island to the proposed island. Sentosa is also set to undergo another major rejuvenation, with enhancements to its beaches and waterfront and improved public access to parts of its western coastline. Following the relocation of port operations, Pulau Brani will be transformed with new attractions, including NTUC’s Downtown South resort. Reclamation and new transport links will better connect Pulau Brani and Sentosa, creating an integrated leisure and tourism destination. Meanwhile, Pulau Tekong could undergo further reclamation along its southern coast, while the government is studying a permanent connection to mainland Singapore, potentially through an undersea tunnel to avoid obstructing shipping channels.
Our view.
These developments should provide a sustained pipeline of reclamation, marine engineering and infrastructure projects, reinforcing visibility beyond the current construction upcycle and easing investor concerns over a potential slowdown in contract awards from 2027 onwards. With expected multi-year construction works in the offing, we believe that early beneficiaries from this 2026 will likely those specialised civil-engineering contractors. Amongst our scan of such players, we note that Hock Lian Seng (Non-rated) appears to a primary direct beneficiary given its track record and focus on dredging works, reclamation and seawall construction, unrestricted BCA A1 civil-engineering licence. Centurion (BUY, TP SGD 1.86), Wee Hur (BUY, TP SGD 0.90) and CAREIT (BUY, TP SGD 1.30) are also early beneficiaries, gaining from initial reclamation and marine-engineering works and higher worker-accommodation demand as contractors mobilise labour. ASL Marine (Non-Rated) could benefit through its fleet of barges, which are used to transport materials, including sand, for reclamation projects. In the medium term, material providers Pan-United (BUY, TP SGD 1.88) and Hong Leong Asia (BUY, TP SGD 5.40) should benefit later as construction progresses to the more concrete-intensive development of seawalls, tunnels, transport links, utilities and buildings. While timelines and project values have yet to be announced, the plans strengthen the sector’s medium- to long-term order-book outlook.